SCHEMBL30815456

SCHEMBL30815456

N#Cc1nccc(NC2CC3(CNC3)C2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 3/20 0.62
▸ HRH3 Q9Y5N1 4/20 0.41
▸ ROCK2 O75116 2/20 0.36
▸ MALT1 Q9UDY8 1/20 0.35
▸ HRH4 Q9H3N8 2/20 0.33
▸ PRKD1 Q15139 1/20 0.33
▸ PRKD2 Q9BZL6 1/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CYP2C19 P33261 1/20 0.32
▸ PRKCB P05771 1/20 0.32
▸ EHMT2 Q96KQ7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27227105 1.00 CTSK (0.62) CTSKHRH3ROCK2MALT1HRH4
SCHEMBL27225969 0.88 CTSK (0.65) CTSKHRH3MALT1HRH4PRKD1
SCHEMBL27226207 0.88 CTSK (0.58) CTSKHRH3ROCK2MALT1HRH4
SCHEMBL30815035 0.88 CTSK (0.58) CTSKHRH3ROCK2MALT1HRH4
SCHEMBL27226113 0.82 CTSK (0.68) CTSKHRH3MALT1HRH4PRKD1
SCHEMBL27311124 0.81 CTSK (0.55) CTSKHRH3ROCK2MALT1CYP1A2
SCHEMBL30815053 0.80 CTSK (0.74) CTSKHRH3MALT1HRH4PRKD1
SCHEMBL27226580 0.80 CTSK (0.74) CTSKHRH3MALT1HRH4PRKD1
SCHEMBL23830884 0.78 CTSK (0.66) CTSKHRH3HRH4CYP1A2CYP2C19
SCHEMBL23830882 0.78 CTSK (0.66) CTSKHRH3HRH4CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594318-A1 AKT1 MODULATORS Alterome Therapeutics, Inc. (US) 2025-08-06 — — EP disclosed
WO-2024073371-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback